版本:
中国

BRIEF-Advaxis says confirms is on track to initiate clinical studies of ADXS-NEO later this year

June 13 Advaxis Inc

* Company confirmed that it is on track to initiate clinical studies of ADXS-NEO later this year

* Reaffirmed plans to file complete MAA for axalimogene filolisbac in Europe for treatment of metastatic cervical cancer by end of 2017​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐